CIRSE Standards of Practice on Thermal Ablation of Primary and Secondary Lung Tumours

Venturini, Massimo; Cariati, Maurizio; Marra, Paolo; Masala, Salvatore; Pereira, Philippe L.; Carrafiello, Gianpaolo

doi:10.1007/s00270-020-02432-6

Cited by 85 publications

(93 citation statements)

References 109 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Percutaneous image-guided thermal ablation with radiofrequency ablation (RFA) has been widely used in the last decade and is established as a potential alternative to surgical resection [ 5 , 6 ]. It is the most suitable for patients with small (< 2 cm) lung metastases and in those who may not be a surgical candidate due to their comorbidities [ 5 , 7 ]. RFA of lung metastases offers a minimally invasive, repeatable treatment, with better preservation of lung function treatment when compared to surgical resection [ 8 ].…”

Section: Introductionmentioning

confidence: 99%

Long-Term Outcomes in Percutaneous Radiofrequency Ablation for Histologically Proven Colorectal Lung Metastasis

Zhong

Palkhi

et al. 2020

Cardiovasc Intervent Radiol

View full text Add to dashboard Cite

Introduction To evaluate the long-term outcome of image-guided radiofrequency ablation (RFA) when treating histologically confirmed colorectal lung metastasis in terms of overall survival (OS), progression-free survival (PFS) and local tumour control (LTC). Materials and Methods Retrospective single-centre study. Consecutive RFA treatments of histologically proven lung colorectal metastases between 01/01/2008 and 31/12/14. The primary outcome was patient survival (OS and PFS). Secondary outcomes were local tumour progression (LTP) and complications. Prognostic factors associated with OS/ PFS were determined by univariate and multivariate analyses. Results Sixty patients (39 males: 21 females; median age 69 years) and 125 colorectal lung metastases were treated. Eighty percent (n = 48) also underwent lung surgery for lung metastases. Mean metastasis size (cm) was 1.4 ± 0.6 (range 0.3–4.0). Median number of RFA sessions was 1 (1–4). During follow-up (median 45.5 months), 45 patients died (75%). The estimated OS and PFS survival rates at 1, 3, 5, 7, 9 years were 96.7%, 74.7%, 44.1%, 27.5%, 16.3% (median OS, 52 months) and 66.7%, 31.2%, 25.9%, 21.2% and 5.9% (median PFS, 19 months). The LTC rate was 90% with 6 patients developing LTP with 1-, 2-, 3- and 4-year LTP rates of 3.3%, 8.3%, 10.0% and 10.0%. Progression-free interval < 1 year (P = 0.002, HR = 0.375) and total number of pulmonary metastases (≥ 3) treated (P = 0.037, HR = 0.480) were independent negative prognostic factors. Thirty-day mortality rate was 0% with no intra-procedural deaths. Conclusion The long-term OS and PFS following RFA for the treatment of histologically confirmed colorectal lung metastases demonstrate comparable oncological durability to surgery.

show abstract

Section: Introductionmentioning

confidence: 99%

Long-Term Outcomes in Percutaneous Radiofrequency Ablation for Histologically Proven Colorectal Lung Metastasis

Zhong

Palkhi

et al. 2020

Cardiovasc Intervent Radiol

View full text Add to dashboard Cite

show abstract

“…Venturini et al. recommended that RFA and MWA present comparable efficacy but MWA is usually considered better tolerated by patients and more suitable for large tumor treatment 53 …”

Section: Comparative Studiesmentioning

confidence: 99%

“…The current evidence, therefore, does not clearly demonstrate a benefit of MWA over RFA in achieving local control in primary lung cancer 52. Venturini et al recommended that RFA and MWA present comparable efficacy but MWA is usually considered better tolerated by patients and more suitable for large tumor treatment 53.…”

mentioning

confidence: 92%

Image‐guided percutaneous microwave ablation of early‐stage non–small cell lung cancer

2020

Asia-Pac J Clncl Oncology

View full text Add to dashboard Cite

Although surgical lobectomy with systematic mediastinal lymph node evaluation is considered as the "gold standard" for management of early stage non-small cell lung cancer (NSCLC), image-guided percutaneous thermal ablation has been increasingly used for medically inoperable patients. Radiofrequency ablation (RFA) is a researchbased technique that has the most studies for medically inoperable early-stage NSCLC. Other thermal ablation techniques used to treat pulmonary tumors include microwave ablation (MWA), cryoablation and laser ablation. MWA has several advantages over RFA including reduced procedural time, reduced heat-sink effect, large ablation zones, decreased susceptibility to tissue impedance, and simultaneous use of multiple antennae. This review article highlights the most relevant updates of MWA for the treatment of early-stage NSCLC, including mechanism of action, clinical outcomes, potential complications, the existing technique problems and future directions.

show abstract

“…Moreover, the release of antigens after ablation may, to a certain extent, enhance the antitumor immunity of the body 4,5 . The safety and effectiveness of thermal ablation for lung tumors has been confirmed in several studies and is widely recognized 6–14 . Clinically, a puncture biopsy is usually required for pathological diagnosis before, or after, thermal ablation.…”

Section: Introductionmentioning

confidence: 99%

Advances in study of the sequence of lung tumor biopsy and thermal ablation

Kong

Wang

et al. 2020

Thoracic Cancer

View full text Add to dashboard Cite

Percutaneous thermal ablation is an important treatment for lung cancer and is widely used in hospitals. Puncture biopsy is generally required for pathological diagnosis before or after thermal ablation. Pathological diagnosis provides both evidence of benign and malignant lesions for ablation therapy and is of important significance for the next step in disease management. Furthermore, the sequence of ablation and biopsy affects the accuracy of pathological diagnosis, the complete ablation rate of thermal ablation, and incidence of surgery‐related complications. Ultimately, it may affect the patient's benefit from local treatment. This article reviews the research progress of traditional asynchronous biopsy followed by ablation, the emerging methods of synchronous biopsy followed by ablation, and synchronous ablation followed by biopsy in the last decade. Key points The sequence of ablation and biopsy affects the accuracy of pathological diagnosis, the complete ablation rate of thermal ablation, and the incidence of surgical‐related complications. This article reviewed the recent 10 years' literature on the surgical sequence of biopsy and ablation for lung tumors, the advantages, disadvantages and indications of different orders were analyzed.

show abstract

CIRSE Standards of Practice on Thermal Ablation of Primary and Secondary Lung Tumours

Cited by 85 publications

References 109 publications

Long-Term Outcomes in Percutaneous Radiofrequency Ablation for Histologically Proven Colorectal Lung Metastasis

Long-Term Outcomes in Percutaneous Radiofrequency Ablation for Histologically Proven Colorectal Lung Metastasis

Image‐guided percutaneous microwave ablation of early‐stage non–small cell lung cancer

Advances in study of the sequence of lung tumor biopsy and thermal ablation

Contact Info

Product

Resources

About